Vlasses PH - Search Results

1

Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals.

Albers GW, Bittar N, Young L, Hattemer CR, Gandhi AJ, Kemp SM, Hall EA, Morton DJ, Yim J, Vlasses PH. Albers GW, et al. Among authors: vlasses ph. Neurology. 1997 Jun;48(6):1598-604. doi: 10.1212/wnl.48.6.1598. Neurology. 1997. PMID: 9191773

2

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Albers GW, et al. Among authors: vlasses ph. Arch Intern Med. 1996 Nov 11;156(20):2311-6. Arch Intern Med. 1996. PMID: 8911237

3

Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals.

Phillips BG, Yim JM, Brown EJ Jr, Bittar N, Hoon TJ, Celestin C, Vlasses PH, Bauman JL. Phillips BG, et al. Among authors: vlasses ph. Am Heart J. 1996 May;131(5):872-8. doi: 10.1016/s0002-8703(96)90167-2. Am Heart J. 1996. PMID: 8615304

4

Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.

Yim JM, Albers GW, Vlasses PH. Yim JM, et al. Among authors: vlasses ph. Ann Pharmacother. 1996 Dec;30(12):1390-5. doi: 10.1177/106002809603001205. Ann Pharmacother. 1996. PMID: 8968449

5

Economic impact of digoxin toxicity.

Gandhi AJ, Vlasses PH, Morton DJ, Bauman JL. Gandhi AJ, et al. Among authors: vlasses ph. Pharmacoeconomics. 1997 Aug;12(2 Pt 1):175-81. doi: 10.2165/00019053-199712020-00007. Pharmacoeconomics. 1997. PMID: 10169669 Clinical Trial.

6

Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction.

Yim JM, Hoon TJ, Bittar N, Bauman JL, Brown EJ Jr, Celestin C, Phillips BG, Vlasses PH. Yim JM, et al. Among authors: vlasses ph. Am J Cardiol. 1995 Jun 1;75(16):1184-6. doi: 10.1016/s0002-9149(99)80757-7. Am J Cardiol. 1995. PMID: 7762512 No abstract available.

7

Quality of care for patients hospitalized with heart failure at academic medical centers.

Nohria A, Chen YT, Morton DJ, Walsh R, Vlasses PH, Krumholz HM. Nohria A, et al. Among authors: vlasses ph. Am Heart J. 1999 Jun;137(6):1028-34. doi: 10.1016/s0002-8703(99)70358-3. Am Heart J. 1999. PMID: 10347327

8

Surveillance of colony-stimulating factor use in US academic health centers.

Yim JM, Matuszewski KA, Vermeulen LC Jr, Ratko TA, Burnett DA, Vlasses PH. Yim JM, et al. Among authors: vlasses ph. Ann Pharmacother. 1995 May;29(5):475-81. doi: 10.1177/106002809502900504. Ann Pharmacother. 1995. PMID: 7544655

9

Albumin and nonprotein colloid solution use in US academic health centers.

Yim JM, Vermeulen LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH. Yim JM, et al. Among authors: vlasses ph. Arch Intern Med. 1995 Dec 11-25;155(22):2450-5. Arch Intern Med. 1995. PMID: 7503604

10

A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation.

Weibert RT, Yeager BF, Wittkowsky AK, Bussey HI, Wilson DB, Godwin JE, Adler DS, Black EA, McGee DL, Vlasses PH. Weibert RT, et al. Among authors: vlasses ph. Ann Pharmacother. 2000 Sep;34(9):981-8. doi: 10.1345/aph.10068. Ann Pharmacother. 2000. PMID: 10981241 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters